IMMB Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume10.00K
Average Volume (3M)N/A
Market Cap
$114.99K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.16
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding574,965,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IMMB FAQ
What was Immunotech Laboratories Inc’s price range in the past 12 months?
Currently, no data Available
What is Immunotech Laboratories Inc’s market cap?
Immunotech Laboratories Inc’s market cap is $114.99K.
When is Immunotech Laboratories Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Immunotech Laboratories Inc’s earnings last quarter?
Currently, no data Available
Is Immunotech Laboratories Inc overvalued?
According to Wall Street analysts Immunotech Laboratories Inc’s price is currently Overvalued.
Does Immunotech Laboratories Inc pay dividends?
Immunotech Laboratories Inc does not currently pay dividends.
What is Immunotech Laboratories Inc’s EPS estimate?
Immunotech Laboratories Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immunotech Laboratories Inc have?
Immunotech Laboratories Inc has 574,965,000 shares outstanding.
What happened to Immunotech Laboratories Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Immunotech Laboratories Inc?
Currently, no hedge funds are holding shares in IMMB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Immunotech Laboratories Inc
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc.
Technical Analysis
Biodexa Pharmaceuticals
―
Scinai Immunotherapeutics
―
PainReform
―
Dermata Therapeutics
―
CDT Equity
―